Early detection of cancer is difficult due to the heterogeneity of the disease. Different types of cancer exhibit varied biological behaviors, making it hard to develop a one-size-fits-all screening method. Additionally, the asymptomatic nature of early-stage cancers often means that they go undetected until they have progressed to more advanced stages. This leads to delayed diagnosis and a lower chance of successful treatment.
